Mabtas N 500 mg Injection 50 ml
₹38672.84*
MRP ₹47162
18% off
₹40088*
MRP ₹47162
15% CB
₹7074 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Mabtas N 500 mg Injection 50 ml belongs to a class of medicines called monoclonal antibodies used in the treatment of non-Hodgkin’s disease and chronic lymphocytic leukaemia. This medicine is also used in treating rheumatoid arthritis in combination with methotrexate and granulomatosis in combination with glucocorticoids. It is also used to treat Pemphigus Vulgaris (PV) and mature B-cell acute leukaemia (B-AL).
Mabtas N 500 mg Injection 50 ml contains Rituximab, which works by inhibiting the DNA and RNA transcription that is essential for cancer cell growth. This helps prevent the growth and further spread of cancerous or non-cancerous cells. On the other hand, Mabtas N 500 mg Injection 50 ml works by interfering with the immune system process that causes inflammation in the joint tissues. Thus, it reduces pain and inflammation and prevents joint damage and disease progression over time
Mabtas N 500 mg Injection 50 ml may cause certain side effects, such as pale skin, painful urination, night sweats, flushing, back pain, nausea, vomiting, diarrhoea, stomach pain, mouth sores, peeling of skin, injection site reactions and pain at the site of injection. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. Mabtas N 500 mg Injection 50 ml is a parenteral preparation. A trained healthcare professional will administer it. Hence, do not self-administer.
Mabtas N 500 mg Injection 50 ml should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Also, inform your doctor if you have liver/kidney disease, hepatitis B virus infection, cardiac disorders, any active infections, or gastrointestinal disorders before receiving this injection. Mabtas N 500 mg Injection 50 ml may cause bowel obstruction and perforation, reactivation of Hepatitis B infection, Cardiac arrhythmias, tumour lysis syndrome, and angina in some patients. Hence, careful monitoring should be done during the entire treatment. Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Mabtas N 500 mg Injection 50 ml contains Rituximab, which belongs to the class of monoclonal antibodies. It works by inhibiting the DNA and RNA transcription that is essential for cancer cell growth. This helps prevent the growth and further spread of cancerous or non-cancerous cells. On the other hand, Mabtas N 500 mg Injection 50 ml works by interfering with the immune system process that causes inflammation in the joint tissues. Thus, it reduces pain and inflammation and prevents joint damage and disease progression over time.
Mabtas N 500 mg Injection 50 ml should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before administration, inform your doctor if you have liver/kidney disease, hepatitis B Virus infection, cardiac disorders, any active infections, or gastrointestinal disorders. Mabtas N 500 mg Injection 50 ml may cause bowel obstruction and perforation, reactivation of Hepatitis B infection, Cardiac arrhythmias, tumour lysis syndrome (tumour cells release their contents into the bloodstream), and angina in some patients. Hence, careful monitoring should be done during the entire treatment. Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Drug-Drug Interactions: Mabtas N 500 mg Injection 50 ml may interact with vaccines, antineoplastic drugs (cisplatin), and other medicines.
Drug-Food Interactions: No interactions found.
Drug-Disease Interactions: Inform your doctor if you have kidney or liver disease, gastrointestinal disorders, and pulmonary disorders before receiving Mabtas N 500 mg Injection 50 ml.
Non-Hodgkin’s Disease: Non-Hodgkin’s disease or Non-Hodgkin’s lymphoma is a blood cancer that affects your lymph system. It causes the uncontrollable growth of cancer cells in the lymph nodes. The lymph system is a part of the immune system which protects your body from disease and infections. Symptoms include lymph node swelling, abdominal pain, chest pain, cough, fever, and night sweats.
Rheumatoid arthritis: It is an auto-immune disease (the body's immune system attacks its tissue) that causes joint pain and damage. It occurs when the immune system does not work properly. Symptoms of rheumatoid arthritis include pain, swelling, stiffness, deformities, and loss of joint function. Mabtas N 500 mg Injection 50 ml is used in combination with methotrexate for the treatment of rheumatoid arthritis.
Chronic lymphocytic leukaemia: It is a type of cancer that occurs in the bone marrow and blood. It increases the number of lymphocytes (a type of white blood cell). The symptoms include fever, enlarged liver, bone or joint pain, shortness of breath, weakness, and bleeding from gums or bruises.
Pemphigus Vulgaris: It is a condition that causes painful blisters on the skin and the lining of the mouth, nose, throat and genitals.
Country of origin
Keep Refrigerated. Do not freeze.Prepaid payment required.
Alcohol
Consult your doctor
It is not known if alcohol interacts with Mabtas N 500 mg Injection 50 ml. Please consult the doctor.
Pregnancy
Caution
If you are pregnant or planning pregnancy, inform your doctor before receiving Mabtas N 500 mg Injection 50 ml. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
Caution
If you are a nursing mother, inform your doctor before receiving Mabtas N 500 mg Injection 50 ml. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Driving
Not applicable
Mabtas N 500 mg Injection 50 ml will be administered in the hospital setting. Hence, avoid driving.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Mabtas N 500 mg Injection 50 ml. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before receiving Mabtas N 500 mg Injection 50 ml. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition.
Children
Consult your doctor
Mabtas N 500 mg Injection 50 ml will be given to the children only if needed. If administered, careful monitoring of the child is needed.
Product Substitutes
We provide you with authentic, trustworthy and relevant information